Israeli - Kiebrania - Ministry of Health

teva israel ltd - tranexamic acid - תמיסה להזרקה - tranexamic acid 500 mg / 5 ml - tranexamic acid - tranexamic acid - general fibrinolysis. this may occur in prostatic and pancreatic carcinoma following thoracic surgery and other major operative procedures, in obstetrical complications such as abruptio placentae and post-partum hemorrhage, in connection with thrombolytic therapy, and in initial and follow-up treatment following prostatectomy and bladder surgery. prior to, and following, dental surgery in hemophiliacs. epistaxis. conization of the cervix.

Israeli - Kiebrania - Ministry of Health

ben shimon floris ltd, israel - salicylic acid - תמיסה כוהלית - salicylic acid 2 %w/v - salicylic acid - salicylic acid - topical antiseptic and keratolytic.

Israeli - Kiebrania - Ministry of Health

hanna drugstore f.a. - salicylic acid - מדבקות - salicylic acid 40 % - salicylic acid - salicylic acid - for the treatment of hard skin on the sole of the foot.

Israeli - Kiebrania - Ministry of Health

hanna drugstore f.a. - salicylic acid - מדבקות - salicylic acid 40 % - salicylic acid - salicylic acid - keratolytic for the removal of corn.

Israeli - Kiebrania - Ministry of Health

dexcel ltd, israel - fusidic acid - קרם - fusidic acid 20 mg/g - fusidic acid - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococus aureus.

Israeli - Kiebrania - Ministry of Health

unipharm ltd, israel - alendronic acid as sodium - טבליה - alendronic acid as sodium 10 mg - alendronic acid - alendronic acid - treatment of osteoporosis in postmenopausal women: maxibone is indicated for the treatment of osteoporosis to prevent fractures, including those of the hip, wrist and spine ( vertebral compression fractures). prevention and treatment of glucocorticoid-induced osteoporosis: maxibone is indicated for the prevention and treatment of glucocorticoid-induced osteoporosis in men and women. for the treatment of osteoporosis in men.

Israeli - Kiebrania - Ministry of Health

teva pharmaceutical industries ltd, israel - alendronic acid as monohydrate - טבליה - alendronic acid as monohydrate 10 mg - alendronic acid - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip, wrist and spine (vertebral compression fractures).for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women. for the treatment to increase bone mass in men with osteoporosis.

Israeli - Kiebrania - Ministry of Health

teva pharmaceutical industries ltd, israel - alendronic acid as monohydrate - טבליה - alendronic acid as monohydrate 10 mg - alendronic acid - alendronic acid - for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip, wrist and spine (vertebral compression fractures).for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women. for the treatment to increase bone mass in men with osteoporosis.

Israeli - Kiebrania - Ministry of Health

abic marketing ltd, israel - risedronic acid as sodium - טבליה - risedronic acid as sodium 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.

Israeli - Kiebrania - Ministry of Health

unipharm ltd, israel - risedronic acid - טבליה - risedronic acid 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.